drugset / Trial / NCT03972462
NPC-12G Gel 0.2% Sirolimus PK Bridging Study
Non-randomizedSequentialOpen-labelOther
Summary
This study is designed to describe the relative systemic bioavailability of topical and oral sirolimus formulations.
Timeline
- Start
- 2019-05-31
- Primary completion
- 2019-06-17
- Completion
- 2019-06-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | 1.6 mg | Topical |
| Subject | Sirolimus | Small molecule | 2 mg | Topical |
Indications
No indication recorded.